吉林省博大制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Levetiracetam Concentrated Solution for injection
- Product Name
- 左乙拉西坦注射用浓溶液
- Approval Number
- 国药准字H20213690
- Approval Date
- Sep 1, 2021
NMPA
Aspirin Enteric-coated Tablets
- Product Name
- 阿司匹林肠溶片
- Approval Number
- 国药准字H22024599
- Approval Date
- Apr 8, 2020
NMPA
Aminopyrine and Caffeine Tablets
- Product Name
- 氨基比林咖啡因片
- Approval Number
- 国药准字H22024869
- Approval Date
- Apr 8, 2020
NMPA
Compound Phenytoin Sodium,Ephedrin Hydrochloride and Theophylline Tablets
- Product Name
- 复方妥英麻黄茶碱片
- Approval Number
- 国药准字H22024079
- Approval Date
- Apr 8, 2020
NMPA
Ephedrine Hydrochloride and Diphenhydramine Hydrochloride Tablets
- Product Name
- 麻黄碱苯海拉明片
- Approval Number
- 国药准字H22025336
- Approval Date
- Apr 8, 2020
NMPA
Ephedrine Hydrochloride and Diphenhydramine Hydrochloride Tablets
- Product Name
- 麻黄碱苯海拉明片
- Approval Number
- 国药准字H22024870
- Approval Date
- Apr 8, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found